Profile
Alfred Dennis Kingsley served as Chairman at AgeX Therapeutics, Inc. He also held the position of Chairman at Lineage Cell Therapeutics, Inc. from 2009 to 2024.
Additionally, he served as Executive Chairman at ES Cell International Pte Ltd., OrthoCyte Corp., and BioTime Asia Ltd.
from 2011 to 2024.
Kingsley was the Executive Chairman at OncoCyte Corp.
from 2009 to 2018.
He served as an Independent Director at Asterias Biotherapeutics, Inc. from 2012 to 2019.
Kingsley was a Director at LifeMap Sciences, Inc., ReCyte Therapeutics, Inc., and Cell Cure Neurosciences Ltd.
He also held the position of Director at Ascendance Biotechnology, Inc. Furthermore, Kingsley served as Senior Vice President at Icahn & Co., Inc. He was the General Partner at Greenway Partners LP and President at Greenbelt Corp.
from 1993 to 2024.
Kingsley obtained an undergraduate degree from The Wharton School of the University of Pennsylvania and a graduate degree from New York University School of Law.
Former positions of Alfred Kingsley
| Companies | Position | End |
|---|---|---|
Greenway Partners LP
 Greenway Partners LP Investment ManagersFinance Greenway Partners LP is the hedge fund management subsidiary of Greenbelt Corp. Headquartered in New York City, the firm manages the assets of high-net-worth clients. | President | 2024-04-23 |
| LINEAGE CELL THERAPEUTICS, INC. | Chairman | 2024-04-23 |
Greenbelt Corp.
 Greenbelt Corp. Investment ManagersFinance Greenbelt Corp. operates as a business consulting firm. The company is headquartered in New York, NY. | President | 2024-04-23 |
ES Cell International Pte Ltd.
 ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Chairman | 2024-04-23 |
ReCyte Therapeutics, Inc.
 ReCyte Therapeutics, Inc. BiotechnologyHealth Technology ReCyte Therapeutics, Inc. operates as a regenerative medicine company. It focuses on repair of vascular disorders, including both age-related diseases and injuries. The company was founded in January 2011 and is headquartered in Alameda, CA. | Director/Board Member | 2024-04-23 |
Training of Alfred Kingsley
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| ONCOCYTE CORPORATION | Health Technology |
| Private companies | 12 |
|---|---|
Greenway Partners LP
Greenway Partners LP Investment ManagersFinance Greenway Partners LP is the hedge fund management subsidiary of Greenbelt Corp. Headquartered in New York City, the firm manages the assets of high-net-worth clients. | Finance |
Greenbelt Corp.
Greenbelt Corp. Investment ManagersFinance Greenbelt Corp. operates as a business consulting firm. The company is headquartered in New York, NY. | Finance |
ReCyte Therapeutics, Inc.
ReCyte Therapeutics, Inc. BiotechnologyHealth Technology ReCyte Therapeutics, Inc. operates as a regenerative medicine company. It focuses on repair of vascular disorders, including both age-related diseases and injuries. The company was founded in January 2011 and is headquartered in Alameda, CA. | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Icahn & Co., Inc.
 Icahn & Co., Inc. Investment Banks/BrokersFinance Icahn & Co., Inc. provides security brokerage and dealership services. It focuses on risk arbitrage and options trading. It offers services to real estate development, oil and gas, railcar leasing, manufacturing, and technology firms. The company was founded in 1968 by Carl Icahn and is headquartered in New York, NY. | Finance |
Cell Cure Neurosciences Ltd.
 Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Health Technology |
OrthoCyte Corp.
 OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Part of Lineage Cell Therapeutics, Inc., OrthoCyte Corp. develops cellular therapeutics for orthopedic repair diseases and injuries. The private company is based in Alameda, CA. The CEO of the company is Michael D. West. | Health Technology |
| BioTime Asia Ltd. | |
LifeMap Sciences, Inc.
 LifeMap Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Atlas Capital Partners Ltd., LifeMap Sciences, Inc. is a private company that provides stem cell information services. The company is based in Alameda, CA. The CEO of the company is Yaron Guan-Golan. LifeMap Sciences was acquired by Atlas Capital Partners Ltd. from AgeX Therapeutics, Inc. on March 15, 2021 for $0.50 million. | Commercial Services |
Ascendance Biotechnology, Inc.
 Ascendance Biotechnology, Inc. BiotechnologyHealth Technology Ascendance Biotechnology, Inc. engages in the sale of cell-based assay products. It offers Hepregen and ESI Bio. The firm also offers stem cell technology. The company was founded by Vincent R. Zurawski, Jr. and Jeffrey D. Janus is headquartered in Alameda, CA. | Health Technology |
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
- Stock Market
- Insiders
- Alfred Kingsley
